Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;99:339-341
doi: 10.1161/01.RES.0000239409.90634.a9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Catalucci, D.
Right arrow Articles by Condorelli, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Catalucci, D.
Right arrow Articles by Condorelli, G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Stem Cells
Related Collections
Right arrowRelated Article
(Circulation Research. 2006;99:339.)
© 2006 American Heart Association, Inc.


Editorials

Effects of Akt on Cardiac Myocytes

Location Counts

Daniele Catalucci, Gianluigi Condorelli

From the Division of Cardiology, Department of Medicine, University of California San Diego, La Jolla; and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Multimedica, Milan, Italy.

Correspondence to Gianluigi Condorelli, Division of Cardiology, Department of Medicine, University of California San Diego, 9500 Gilman Dr, La Jolla, CA 92093-0734. E-mail gcondorelli@ucsd.edu



See related article, pages 381–388


Key Words: Akt • stem cell • signaling • cardiomyocytes • hypertrophy


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

"Akt quisque ipse faber fortunae suae... " (Each Akt makes its own destiny....)

During the last few years, Akt (protein kinase B [PKB]) has become among the most studied signal-transduction molecules in cardiac biology. Akt is, in fact, at the crossroads of the insulin- and insulin-like growth factor-1 (IGF-1)–activated signal-transduction pathways. After insulin or IGF-1 interacts with its respective receptor, phosphatidylinositol 3-kinase (PI3K) phosphorylates inositol lipids that then bind to the pleckstrin domain of Akt, inducing its translocation to the plasma membrane. Here, Akt becomes the substrate of 3'-phosphoinositide-dependent kinase-1 (PDK-1), which activates it through phosphorylation of Thr308. Once active, Akt phosphorylates a number of "effector" substrates throughout the cell after migrating to subcellular organelles, including nuclei and mitochondria and other cytosolic locations. Therefore, the regulation of specific cellular functions is exerted by Akt at the level of the plasma membrane, nucleus, mitochondria, and cytosol in multiprotein complexes (Figure).


Figure Removed (Available Only in the Full Text)
View larger version (40K):
[in this window]
[in a new window]
 
Binding of insulin (Ins) or IGF-1 activates PI3K and generates inositol lipids that bind to the pleckstrin domain of Akt, which is therefore localized to the plasma membrane where it becomes the substrate of PDK-1. Once activated, Akt migrates on plasma membrane itself, cytoplasm, mitochondria, and nucleus, phosphorylating key effector molecules. The result of this multitude of effects is improvement of metabolism, inotropism, and survival.

Models for studying the role of Akt, or its upstream molecules, in cardiac biology include cardiac-specific transgenic and knockout mice. Akt harboring mutations in either its pleckstrin or kinase domain, or containing . . . [Full Text of this Article]


Related Article:

Akt Promotes Increased Cardiomyocyte Cycling and Expansion of the Cardiac Progenitor Cell Population
Natalie Gude, John Muraski, Marta Rubio, Jan Kajstura, Erik Schaefer, Piero Anversa, and Mark A. Sussman
Circ. Res. 2006 99: 381-388. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. Catalucci, M. V. G. Latronico, M. Ceci, F. Rusconi, H. S. Young, P. Gallo, M. Santonastasi, A. Bellacosa, J. H. Brown, and G. Condorelli
Akt Increases Sarcoplasmic Reticulum Ca2+ Cycling by Direct Phosphorylation of Phospholamban at Thr17
J. Biol. Chem., October 9, 2009; 284(41): 28180 - 28187.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Y. Oudit and J. M. Penninger
Cardiac regulation by phosphoinositide 3-kinases and PTEN
Cardiovasc Res, May 1, 2009; 82(2): 250 - 260.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Miyamoto, M. Rubio, and M. A. Sussman
Nuclear and mitochondrial signalling Akts in cardiomyocytes
Cardiovasc Res, May 1, 2009; 82(2): 272 - 285.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
D. Catalucci, D.-H. Zhang, J. DeSantiago, F. Aimond, G. Barbara, J. Chemin, D. Bonci, E. Picht, F. Rusconi, N. D. Dalton, et al.
Akt regulates L-type Ca2+ channel activity by modulating Cav{alpha}1 protein stability
J. Cell Biol., March 23, 2009; 184(6): 923 - 933.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Caporali and C. Emanueli
Cardiovascular Actions of Neurotrophins
Physiol Rev, January 1, 2009; 89(1): 279 - 308.
[Abstract] [Full Text] [PDF]